⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CSTL News
Castle Biosciences, Inc. Common Stock
Castle Biosciences to Present at the Canaccord Genuity 46th Annual Growth Conference
prnewswire.com
CSTL
Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test
prnewswire.com
CSTL
DecisionDx®-Melanoma's i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy
prnewswire.com
CSTL
Castle Biosciences' Chief Financial Officer Frank Stokes Named a 2026 CFO Awards Honoree by the Houston Business Journal
prnewswire.com
CSTL
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
prnewswire.com
CSTL
Castle Biosciences' TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barrett's Esophagus
prnewswire.com
CSTL
Form 8-K
sec.gov
CSTL
Worldwide NFT, Inc. Announces Change of Control, Recapitalization
globenewswire.com
CSTL
Castle Biosciences to Present at the 2026 Jefferies Global Healthcare Conference
prnewswire.com
CSTL
Castle Biosciences' AdvanceAD-Tx™ Test Receives 2026 MedTech Breakthrough Award for Genomics Innovation
prnewswire.com
CSTL